Position in HIMS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$29,851,076
+$16,577,714 QoQ
Shares Held
861,006
+34.7% QoQ
Ownership
0.369%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#26
of 504 holders
Holding Since
Mar 2022
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Derivatives in HIMS
reported options exposure · as of Jun 30, 2026CallValue
$8,667,500
CallShares
250,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $487,957,812 across 61 Drug Manufacturers - Specialty & Generic names. HIMS ranks #7 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
2,302,737 | $165,474,680 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
324,807 | $54,742,970 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,343,554 | $45,519,608 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
72,010 | $39,017,177 | |
| 5 | VTRS |
Viatris Inc
|
2,437,004 | $38,699,622 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
907,024 | $37,215,193 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
This page
|
861,006 | $29,851,076 | |
| 8 | ALKS |
Alkermes plc.
|
219,935 | $11,524,592 |
All Filings in HIMS
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,851,076 | 861,006 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $8,667,500 | 250,000 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $3,207,420 | 154,500 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $5,190,000 | 250,000 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $13,273,362 | 639,372 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $30,959,202 | 953,471 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $8,085,030 | 249,000 | Put | Sole | 2026-02-13 | |
| 2025-12-31 | $9,091,600 | 280,000 | Call | Sole | 2026-02-13 | |
| 2024-06-30 | $5,676,055 | 281,132 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,365,502 | 152,909 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,979,960 | 334,827 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $1,958,209 | 311,321 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $5,510,844 | 586,260 | Shares | Sole | 2023-09-20 | |
| 2023-03-31 | $2,816,545 | 283,926 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $208,889 | 32,588 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $28,714 | 5,146 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $27,596 | 6,092 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,924 | 361 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||